MedPath
TGA Approval

Entity SL-NAD+ 100mg (459386)

459386

Entity SL-NAD+ 100mg

iX Biopharma Pty Ltd

August 13, 2024

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

nadide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Entity SL-NAD+ 100mg (459386) - TGA 批准文号 | MedPath